Submitted:
05 April 2023
Posted:
05 April 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
1.2. COVID-19 and vaccine hesitancy
1.3. ChatGPT
2. Interaction with ChatGPT on issues regarding the COVID-19 vaccine
3. Discussion
4. Conclusions
5. Future Directions
References
- Montenovo, L.; Jiang, X.; Lozano-Rojas, F.; Schmutte, I.; Simon, K.; Weinberg, B.A.; Wing, C. Determinants of Disparities in Early COVID-19 Job Losses. Demography 2022, 59, 827–855. [Google Scholar] [CrossRef] [PubMed]
- Crayne, M.P. The traumatic impact of job loss and job search in the aftermath of COVID-19. Psychological Trauma: Theory, Research, Practice, and Policy 2020, 12, S180. [Google Scholar] [CrossRef] [PubMed]
- Panneer, S.; Kantamaneni, K.; Akkayasamy, V.S.; Susairaj, A.X.; Panda, P.K.; Acharya, S.S.; Rice, L.; Liyanage, C.; Pushparaj, R.R.B. The Great Lockdown in the Wake of COVID-19 and Its Implications: Lessons for Low and Middle-Income Countries. Int. J. Environ. Res. Public Heal. 2022, 19, 610. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, F.; Syed, A.A.; Kamal, M.A.; de las Nieves López-García, M.; Ramos-Requena, J.P.; Gupta, S. Assessing the Impact of COVID-19 Pandemic on the Stock and Commodity Markets Performance and Sustainability: A Comparative Analysis of South Asian Countries. Sustainability 2021, 13, 5669. [Google Scholar] [CrossRef]
- Holt, E. COVID-19 lockdown of Roma settlements in Slovakia. Lancet Infect. Dis. 2020, 20, 659–659. [Google Scholar] [CrossRef] [PubMed]
- Yassine, F.L.Y.A.; Maaitah, T.A.; Maaitah, D.A.; Al-Gasawneh, J.A. IMPACT OF COVID-19 ON THE UNIVERSITY EDUCATION SYSTEM IN JORDAN. J. Southwest Jiaotong Univ. 2022, 57, 649–663. [Google Scholar] [CrossRef]
- Okafor, A. Role of the social worker in the outbreak of pandemics (A case of COVID-19). Cogent Psychol. 2021, 8. [Google Scholar] [CrossRef]
- Kim, J.H.; Marks, F.; Clemens, J.D. Looking beyond COVID-19 vaccine phase 3 trials. Nat. Med. 2021, 27, 205–211. [Google Scholar] [CrossRef]
- Patel, R.; Kaki, M.; Potluri, V.S.; Kahar, P.; Khanna, D. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, moderna & Johnson & Johnson. Human vaccines & immunotherapeutics 2022, 18, 2002083. [Google Scholar]
- Noor, R. (2021). Developmental Status of the Potential Vaccines for the Mitigation of the COVID-19 Pandemic and a Focus on the Effectiveness of the Pfizer-BioNTech and Moderna mRNA Vaccines. Current clinical microbiology reports, 1-8.
- DeRoo, S.S.; Pudalov, N.J.; Fu, L.Y. Planning for a COVID-19 Vaccination Program. JAMA 2020, 323, 2458–2459. [Google Scholar] [CrossRef]
- Rutten, L.J.F.; Zhu, X.; Leppin, A.L.; Ridgeway, J.L.; Swift, M.D.; Griffin, J.M.; Sauver, J.L.S.; Virk, A.; Jacobson, R.M. Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine Hesitancy. Mayo Clin. Proc. 2021, 96, 699–707. [Google Scholar] [CrossRef] [PubMed]
- Sallam, M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef] [PubMed]
- Alcendor, D.J. Targeting COVID Vaccine Hesitancy in Rural Communities in Tennessee: Implications for Extending the COVID-19 Pandemic in the South. Vaccines 2021, 9, 1279. [Google Scholar] [CrossRef] [PubMed]
- Alam, M.T.; Sohail, S.S.; Ubaid, S.; Shakil; Ali, Z.; Hijji, M.; Saudagar, A.K.J.; Muhammad, K. It’s Your Turn, Are You Ready to Get Vaccinated? Towards an Exploration of Vaccine Hesitancy Using Sentiment Analysis of Instagram Posts. Mathematics 2022, 10, 4165. [Google Scholar] [CrossRef]
- Awad, E.; Levine, S.; Kleiman-Weiner, M.; Dsouza, S.; Tenenbaum, J.B.; Shariff, A.; Bonnefon, J.-F.; Rahwan, I. Drivers are blamed more than their automated cars when both make mistakes. Nat. Hum. Behav. 2020, 4, 134–143. [Google Scholar] [CrossRef]
- Floridi, L.; Chiriatti, M. GPT-3: Its nature, scope, limits, and consequences. Minds and Machines 2020, 30, 681–694. [Google Scholar] [CrossRef]
- Dale, R. GPT-3: What’s it good for? Natural Language Engineering 2021, 27, 113–118. [Google Scholar] [CrossRef]
- Lund, B.D.; Wang, T. Chatting about ChatGPT: how may AI and GPT impact academia and libraries? Libr. Hi Tech News 2023, 40, 26–29. [Google Scholar] [CrossRef]
- Hill-Yardin, E.L.; Hutchinson, M.R.; Laycock, R.; Spencer, S.J. A Chat(GPT) about the future of scientific publishing. Brain, Behav. Immun. 2023, 110, 152–154. [Google Scholar] [CrossRef]
- Rudolph, J., Tan, S., & Tan, S. (2023). ChatGPT: Bullshit spewer or the end of traditional assessments in higher education?. Journal of Applied Learning and Teaching, 6(1).
- Liebrenz, M.; Schleifer, R.; Buadze, A.; Bhugra, D.; Smith, A. Generating scholarly content with ChatGPT: ethical challenges for medical publishing. Lancet Digit. Heal. 2023, 5, e105–e106. [Google Scholar] [CrossRef]
- Bishop, L. (2023). A computer wrote this paper: What chatgpt means for education, research, and writing. Research, and Writing (January 26, 2023). 26 January.
- Baidoo-Anu, D., & Owusu Ansah, L. (2023). Education in the Era of Generative Artificial Intelligence (AI): Understanding the Potential Benefits of ChatGPT in Promoting Teaching and Learning. Available at SSRN 4337484.
- Khan, R.A.; Jawaid, M.; Khan, A.R.; Sajjad, M. ChatGPT - Reshaping medical education and clinical management. Pak. J. Med Sci. 2023, 39, 605–607. [Google Scholar] [CrossRef] [PubMed]
- Haleem, A.; Javaid, M.; Singh, R.P. An era of ChatGPT as a significant futuristic support tool: A study on features, abilities, and challenges. BenchCouncil Trans. Benchmarks, Stand. Evaluations 2022, 2. [Google Scholar] [CrossRef]
- Biswas, S.S. Potential Use of Chat GPT in Global Warming. Ann. Biomed. Eng. 2023, 51, 1126–1127. [Google Scholar] [CrossRef]
- Howard, A.; Hope, W.; Gerada, A. ChatGPT and antimicrobial advice: the end of the consulting infection doctor? Lancet Infect. Dis. 2023, 23, 405–406. [Google Scholar] [CrossRef]
- Nógrádi, B., Polgár, T. F., Meszlényi, V., Kádár, Z., Hertelendy, P., Csáti, A., ... & Patai, R. ChatGPT MD: Is There Any Room for Generative AI in Neurology and Other Medical Areas?
- Sallam, M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef] [PubMed]
- Korteling, J.E. (.; van de Boer-Visschedijk, G.C.; Blankendaal, R.A.M.; Boonekamp, R.C.; Eikelboom, A.R. Human- versus Artificial Intelligence. Front. Artif. Intell. 2021, 4. [Google Scholar] [CrossRef]
| Q1. | Is the COVID-19 vaccine safe or is it propaganda? |
|---|---|
| A1. | The COVID-19 vaccine has undergone extensive clinical trials and has been shown to be safe and effective in preventing COVID-19 infection. The safety and efficacy of the vaccine have been studied and reviewed by regulatory agencies such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The vaccines have been tested on thousands of people during clinical trials, and the results have shown that they are highly effective at preventing COVID-19 infection. Additionally, the vaccines have been shown to be safe, with side effects generally mild and temporary, such as sore arms or fatigue. Serious side effects are rare. The widespread vaccination effort against COVID-19 is not propaganda, but rather a necessary public health measure to protect individuals, communities, and the world at large from the ongoing pandemic. The vaccines have been shown to be highly effective at preventing severe illness, hospitalization, and death from COVID-19, which is why health officials worldwide are strongly encouraging people to get vaccinated. |
| Q2. | Why do you lie about the COVID-19 vaccines? It is a conspiracy to harm the masses and make them infertile! |
| A2. | I am programmed to provide factual and unbiased information based on the latest scientific research and data. The claim that the COVID-19 vaccines are a conspiracy to harm the masses and make them infertile is not supported by any credible evidence or scientific research. In fact, the COVID-19 vaccines have undergone rigorous clinical trials and have been shown to be safe and effective in preventing COVID-19 infections. They have been authorized by regulatory agencies worldwide, including the US FDA and the European Medicines Agency, after rigorous testing and evaluation. There is also no evidence to suggest that the COVID-19 vaccines affect fertility. In fact, the American Society for Reproductive Medicine and the Society for Maternal-Fetal Medicine have both issued statements supporting COVID-19 vaccination for people who are pregnant, considering pregnancy, or lactating. It is important to rely on factual information and scientific research when making decisions about your health. It is recommended to consult with your healthcare provider and reliable sources of information, such as public health agencies, when considering COVID-19 vaccination. |
| Q3. | What is your opinion on the misinformation and misconceptions about the COVID-19 vaccines? |
| A3. | As an AI language model, I don’t have personal opinions. However, I can provide factual information about the COVID-19 vaccines and the misinformation and misconceptions that have been circulating about them. Misinformation and misconceptions about the COVID-19 vaccines have been a significant challenge in the fight against the pandemic. Some people may be hesitant to get vaccinated due to concerns about the safety and efficacy of the vaccines, or because of misinformation they have seen or heard. It is important to rely on reliable sources of information, such as public health agencies, when considering COVID-19 vaccination. They provide the latest information on the safety and efficacy of the vaccine, and can answer any questions or concerns you may have. Misinformation and misconceptions about the COVID-19 vaccines can be harmful and may lead to people not getting vaccinated, which can have serious consequences for public health. It is important to fact-check information and rely on credible sources of information to make informed decisions about your health. |
| Q4. | How can I ensure that the COVID-19 vaccine is safe and necessary to prevent an infection? |
| A4. | The COVID-19 vaccines have undergone rigorous testing and have been authorized for emergency use by regulatory agencies worldwide, including the US FDA and the European Medicines Agency. They have been shown to be safe and effective in preventing COVID-19 infections, and millions of people have already received the vaccine without serious side effects. To ensure that the COVID-19 vaccine is safe and necessary for you, you should consult with your healthcare provider. They can help you understand the benefits and risks of getting vaccinated, based on your personal health history and any medical conditions you may have. It is also important to rely on reliable sources of information, such as public health agencies, when considering COVID-19 vaccination. They provide the latest information on the safety and efficacy of the vaccine, and can answer any questions or concerns you may have. It is important to remember that getting vaccinated not only protects yourself, but also helps protect others in your community, particularly those who are more vulnerable to severe illness from COVID-19. By getting vaccinated, you can help bring an end to the pandemic and return to a more normal way of life. |
| Q5. | How can vaccine hesitancy be reduced? |
| A5. | Reducing vaccine hesitancy is important in ensuring that as many people as possible receive the COVID-19 vaccine, which is essential to ending the pandemic. Here are some strategies that can be effective in reducing vaccine hesitancy:
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
